Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Parulekar

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of the National Cancer Institute|May 4, 2006
Sentinel lymph node biopsy in early breast cancer: has its time come?Joseph Pater, Wendy Parulekar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Influence of sex on toxicity and treatment outcome in small-cell lung cancerSimron Singh, Wendy Parulekar, Nevin Murray, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 20, 2002
Ethics and industry-sponsored researchJoseph L Pater, Wendy Parulekar, Christopher O'Callagham, et al.
The Breast Journal|July 16, 2009
Primary basaloid carcinoma of the nipple with associated squamous cell carcinoma in situChien-Hung Chen, Caroline Rowlands, Sandip K Sengupta, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancerWendy Parulekar, Robert W de Marsh, Rebecca Wong, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2021
Influence of the competing risk of death on estimates of disease recurrence in trials of adjuvant endocrine therapy for early-stage breast cancer: A secondary analysis of MA.27, MA.17 and MA.17RJosee-Lyne Ethier, Geoffrey M Anderson, Peter C Austin, et al.
Journal of the National Cancer Institute|February 14, 2008
Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancerJudith-Anne W Chapman, Daniel Meng, Lois Shepherd, et al.
Cancer|September 9, 2010
Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3Gilda da Cunha Santos, Neesha Dhani, Dongsheng Tu, et al.
Oral Oncology|February 1, 2021
Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: An international practice pattern surveyJohn R de Almeida, Valerie Seungyeon Kim, Brian O'Sullivan, et al.
BJU International|April 13, 2007
Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomyChris Parker, Matthew R Sydes, Charles Catton, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of the National Cancer Institute|May 4, 2006
Sentinel lymph node biopsy in early breast cancer: has its time come?Joseph Pater, Wendy Parulekar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Influence of sex on toxicity and treatment outcome in small-cell lung cancerSimron Singh, Wendy Parulekar, Nevin Murray, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 20, 2002
Ethics and industry-sponsored researchJoseph L Pater, Wendy Parulekar, Christopher O'Callagham, et al.
The Breast Journal|July 16, 2009
Primary basaloid carcinoma of the nipple with associated squamous cell carcinoma in situChien-Hung Chen, Caroline Rowlands, Sandip K Sengupta, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancerWendy Parulekar, Robert W de Marsh, Rebecca Wong, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2021
Influence of the competing risk of death on estimates of disease recurrence in trials of adjuvant endocrine therapy for early-stage breast cancer: A secondary analysis of MA.27, MA.17 and MA.17RJosee-Lyne Ethier, Geoffrey M Anderson, Peter C Austin, et al.
Journal of the National Cancer Institute|February 14, 2008
Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancerJudith-Anne W Chapman, Daniel Meng, Lois Shepherd, et al.
Cancer|September 9, 2010
Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3Gilda da Cunha Santos, Neesha Dhani, Dongsheng Tu, et al.
Oral Oncology|February 1, 2021
Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: An international practice pattern surveyJohn R de Almeida, Valerie Seungyeon Kim, Brian O'Sullivan, et al.
BJU International|April 13, 2007
Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomyChris Parker, Matthew R Sydes, Charles Catton, et al.
Pageof 3